[ET Net News Agency, 1 April 2026] PHARMARON (03759) rose 10.1% to HK$20.72.
It hits an intra-day high of HK$20.72, breaking above the 250-D SMA of HK$20.019, and an intra-day low of HK$19.14. The total shares traded was 10.68 million, with a value of HK$213.9m. The active buy/sell ratio is 73:27, with net buying turnover of HK$92.89m. J.P. MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$1.23m, with volume weighted average price of HK$20.019. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$27.77m, with volume weighted average price of HK$20.095. The stock has risen a combined 13.4% over the past 2 consecutive trading days.
Basic Information| Nominal | 20.720 | % Chg | +10.10% |
| High | 20.720 | Low | 19.140 |
| Shares Tr | 10.68m | Turnover | 213.9m |
| 10-D SMA | 18.578 | %H.V | 53.111 |
| 20-D SMA | 18.896 | VWAP | 20.033 |
| 50-D SMA | 19.942 | RSI14 | 59.370 |
Status: Breaking above the 250-D SMA, active buy/sell ratio is 73:27, with net buying turnover of HK$92.89m, rising a combined 13.4% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| PHARMARON (03759) | 20.72 | +10.10 |
| INNOVENT BIO (01801) | 90.75 | +6.89 |
| KEYMED BIO-B (02162) | 66.95 | +10.30 |
| XTALPI (02228) | 9.68 | +7.44 |
| WUXI XDC (02268) | 61.75 | +6.10 |
| WUXI BIO (02269) | 35.08 | +6.24 |
| WUXI APPTEC (02359) | 124.30 | +5.79 |
| BEONE MEDICINES (06160) | 184.90 | +7.75 |
| AKESO (09926) | 139.80 | +7.37 |
| REMEGEN (09995) | 109.60 | +14.40 |
(ed)
